Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide LAR for head-and-neck paraganglioma
2006-002603-13Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- May 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of octreotide in Paraganglioma (PGL), sponsored by Leiden University Medical Center. Primary endpoint: tumor volume. Started May 2006; status: terminated.
02
Drugs
octreotide
03
Conditions
Paraganglioma (PGL)
Beyond the preview
Go deeper on 2006-002603-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002603-13.